周力,陈晖,马清,孙颖,李东宝,赵慧强,李虹伟

• 1:首都医科大学附属北京友谊医院医疗保健中心
• 2:首都医科大学附属北京友谊医院心脏中心

摘要(Abstract)：

目的探讨合并血小板减少的急性冠状动脉综合征(ACS)患者的临床特点、治疗及预后。方法 2012年3月至2013年3月北京友谊医院共完成PCI术1186例,有11例术前血小板低于100×109/L的ACS患者,占总例数的0.93%,回顾性分析11例患者的相关临床情况。结果11例患者中,急性ST段抬高心肌梗死(STEMI)6例(54.5%),非急性ST段抬高心肌梗死(NSTEMI)3例(27.3%),不稳定型心绞痛(UAP)2例(18.2%)。5例(45.5%)STEMI患者行急诊PCI治疗,其余6例(54.5%)行择期PCI治疗。造影显示左主干+三支血管病变3例(27.3%),其余8例(72.7%)均为三支血管病变。术后随访(14.4±2.3)个月,期间3例(27.3%)发生出血并发症,3例(27.3%)发生主要不良心血管事件。结论本组患者的冠状动脉病变以多支病变、复杂病变为主,临床预后不良。

关键词(KeyWords)： 血小板减少;急性冠状动脉综合征;血管成形术;经皮冠状动脉

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 周力,陈晖,马清,孙颖,李东宝,赵慧强,李虹伟

参考文献(References)：

• [1]Yadav M,Genereux P,Kirtane AJ,et al.TCT-244 Baseline Thrombocytopenia:A Strong Predic tor Of One-Year Adverse Ischemic Events In Patients With ACS Undergoing PCI:A Pooled analysis From ACUITY And HORIZONS-AMI Trials.J Am Coll Cardiol,2013,62:B80.
• [2]Rossi C,Randi ML,Zerbinati P,et al.Acute coronary disease in essential thrombocythemia and polycythemia vera.J Intern Med,1998,244:49-53.
• [3]Odell TT,Murphy JR,Jackson CW.Stimulation of megakaryocytopoiesis by acute thrombocytopenia in rats.Blood,1976,48:765-775.
• [4]VanWijk MJ,VanBavel E,Sturk A,et al.Microparticles in cardiovascular diseases.Cardiovasc Res,2003,59:277-287.
• [5]Jy W,Horstman LL,Arce M,et al.Clinical significance of platelet microparticles in autoimmune thrombocytopenias.J Lab Clin Med,1992,119:334-345.
• [6]Ozner MD,Ahn YS,Horstman LL,et al.Chronic platelet activation and acute coronary syndromes in 13 middle-aged patients.Clin Appl Thromb Hemost,1997,3:46-53.
• [7]Solomons HD,Stanley A,King PC,et al.Acute promyelocytic leukaemia associated with acute myocardial infarction.A case report.S Afr Med J,1986,70:117-118.
• [8]Manor SM,Guillory GS,Jain SP.Clopidogrel-induced thrombotic thrombocytopenic purpura-hemolytic uremic syndrome after coronary artery stenting.Pharmacotherapy,2004,24:664-667.
• [9]于凝,惠永明,马超,等.非ST段抬高型急性冠状动脉综合征患者经皮冠状动脉介入治疗术后强化抗血小板治疗临床效果.中国介入心脏病学杂志,2012,20:199-203.
• [10]Overgaard CB,Ivanov J,Seidelin PH,et al.Thrombocytopenia at baseline is a predictor of in hospital mortality in patients undergoing percutaneous coronary intervention.Am Heart J,2008,156:120-124.
• [11]Daniel BS,Peter JP,Stephen K,et al.Outcomes after PCI in patients with thrombocytopenia.J Am Coll Cardiol,2013,61:1718.